Egyptian Center for Research and Regenerative Medicine

Quick facts

Phase 2 pipeline

• Specific anti-SARS-CoV-2 antibodies

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Egyptian Center for Research and Regenerative Medicine portfolio CI brief
• Egyptian Center for Research and Regenerative Medicine pipeline updates RSS

Related

• Sector hub: All tracked pharma companies